Market revenue in 2023 | USD 14.0 million |
Market revenue in 2030 | USD 24.4 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Sequencing by synthesis |
Fastest growing segment | Sequencing by synthesis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sequencing by synthesis, Sequencing by ligation, Sanger sequencing |
Key market players worldwide | Microbiome Insights Inc., BaseClear, Clinical Microbiomics, Mérieux NutriSciences Corporation, Mr Dna, Metabiomics, Rancho BioSciences, Second Genome, Zymo Research, uBiome |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microbiome sequencing services market will help companies and investors design strategic landscapes.
Sequencing by synthesis was the largest segment with a revenue share of 59.29% in 2023. Horizon Databook has segmented the Denmark microbiome sequencing services market based on sequencing by synthesis, sequencing by ligation, sanger sequencing covering the revenue growth of each sub-segment from 2018 to 2030.
According to the World Population Review, in 2022, Denmark was ranked 5th globally in terms of number of cancer cases. Thus, the high burden of target conditions is fueling the demand for advanced therapeutics and diagnostics.
The country’s market is majorly driven by the significantly growing demand for precision medicine, rising R&D expenditure by biopharmaceutical companies, and evolving biotechnology sector in the country. For instance, according to the Ministry of Foreign Affairs of Denmark, the country is ranked 3rd in Europe in the biotechnology sector and has the world’s greatest percentage of patents in biotechnology.
Moreover, favorable research environment in the country and presence of a large number of microbiome sequencing service providers are anticipated to propel the country’s market. For instance, in October 2022, Clinical Microbiomics, a Danish microbiome company acquired MSOmics, a leading metabolomics provider.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark microbiome sequencing services market , including forecasts for subscribers. This country databook contains high-level insights into Denmark microbiome sequencing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account